Table 1. Summary table of number of SAC treated for STH in LF-endemic countries in WHO regions, 2014.
LF non- endemic | LF endemic | PC stopped | LF endemicity unknown | Total | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Indicator | # IU | SAC | # IU | SAC | # IU | SAC | # IU | SAC | # IU | SAC* | |
AFRO | TOTAL | 1,704 | 81,054,011 | 1,818 | 95,881,982 | 87 | 4,812,971 | 58 | 2,458,040 | 3,667 | 184,207,004 |
Treated LF | 4 | 109,952 | 1,129 | 49,803,435 | 5 | 212,116 | 0 | 0 | 1,138 | 50,125,503 | |
Treated STH | 521 | 19,680,559 | 599 | 21,431,675 | 39 | 1,950,855 | 3 | 2,775 | 1,162 | 43,065,864 | |
Overlapping | 2 | 55,207 | 435 | 12,677,897 | 2 | 81,378 | 0 | 0 | 439 | 12,814,482 | |
AMRO | TOTAL | 22 | 1,574,968 | 123 | 2,723,988 | 66 | 9,121,568 | 0 | 0 | 211 | 13,420,524 |
Treated LF | 0 | 0 | 81 | 1,325,787 | 0 | 0 | 0 | 0 | 79 | 1,325,787 | |
Treated STH | 22 | 1,172,786 | 11 | 759,163 | 32 | 4,934,866 | 0 | 0 | 65 | 6,866,815 | |
Overlapping | 0 | 0 | 3 | 103,567 | 0 | 0 | 0 | 0 | 3 | 103,567 | |
EMRO | TOTAL | 24 | 1,279,742 | 30 | 1,694,741 | 0 | 0 | 130 | 8,126,024 | 184 | 11,100,507 |
Treated LF | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Treated STH | 2 | 5,533 | 0 | 0 | 0 | 0 | 12 | 325,493 | 14 | 331,026 | |
Overlapping | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
SEARO | TOTAL | 338 | 44,333,448 | 485 | 129,052,478 | 141 | 45,171,143 | 1 | 326,310 | 965 | 218,883,379 |
Treated LF | 0 | 0 | 336 | 82,163,334 | 0 | 0 | 0 | 0 | 336 | 82,163,334 | |
Treated STH | 69 | 18,439,645 | 116 | 23,252,269 | 43 | 7,465,774 | 0 | 0 | 228 | 49,157,688 | |
Overlapping | 0 | 0 | 98 | 14,006,083 | 0 | 0 | 0 | 0 | 98 | 14,006,083 | |
WPRO | TOTAL | 36 | 11,142,460 | 22 | 4,218,431 | 23 | 3,894,861 | 0 | 0 | 81 | 19,255,752 |
Treated LF | 0 | 0 | 22 | 4,218,431 | 0 | 0 | 0 | 0 | 22 | 4,218,431 | |
Treated STH | 27 | 4,571,347 | 17 | 1,980,755 | 18 | 1,579,257 | 0 | 0 | 62 | 8,131,359 | |
Overlapping | 0 | 0 | 17 | 1,909,761 | 0 | 0 | 0 | 0 | 17 | 1,909,761 |
*SAC population includes districts with STH prevalence below 20%
(Source of data: PCT databank, http://www.who.int/neglected_diseases/preventive_chemotherapy/databank/en/)